跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IR-2
首页
药物
IR-2
IR-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
US 6946688 B2
申请人: DU PONT
优先权: 2003
US
14 件公开
US 6979739 B2
申请人: DU PONT
优先权: 2001
US
7 件公开
US 2002190250 A1
申请人: GRUSHIN VLADIMIR
优先权: 2001
US
2 件公开
US 7132681 B2
申请人: DU PONT
优先权: 2003
US
2 件公开
NOVEL HYDROPHILIC DERIVATIVES OF 2-ARYL-4-QUINOLONES AS ANTICANCER AGENTS
US 2010168064 A1
申请人: UNIV CHINA MEDICAL
优先权: 2007
US
8 件公开
Metal coordination compound, luminescence device and display apparatus
US 6991857 B2
申请人: CANON KK
优先权: 2000
CN
US
5 件公开
GUIDE RNAS AND USES THEREOF
EP 4039808 A1
申请人: OSPEDALE SAN RAFFAELE SRL
优先权: 2021
EP
US
WO
4 件公开
ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME
EP 4124642 A1
申请人: LG DISPLAY CO LTD
优先权: 2021
CN
EP
US
4 件公开
NEW COUMARIN-POLYMER CONJUGATES AND USES THEREOF
EP 4138941 B1
申请人: ONYEL BIOTECH S R L
优先权: 2020
EP
US
WO
3 件公开
IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME
EP 4349814 A1
申请人: MITSUBISHI CHEM CORP
优先权: 2021
CN
EP
WO
3 件公开
CRYSTALLINE SALTS OF LINSITINIB FOR TREATING THYROID EYE DISEASE
EP 4731628 A1
申请人: SLING THERAPEUTICS INC
优先权: 2023
CN
EP
US
3 件公开
WO 2024263609 A9
申请人: SLING THERAPEUTICS INC
优先权: 2023
WO
Compounds and compositions as protein kinase inhibitors
US 7846923 B2
申请人: IRM LLC
优先权: 2007
CN
US
3 件公开
US 7423038 B2
申请人: IRM LLC
优先权: 2005
US
2 件公开
CN 101031568 A
申请人: IRM LLC
优先权: 2004
CN
Compounds and compositions as kinase inhibitors
US 8518931 B2
申请人: JIANG TAO
优先权: 2009
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈